Brevan Howard Capital Management’s Repligen RGEN Stock Holding History

Brevan Howard Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$202K	Buy	+1,481	New	+$182K	﹤0.01%	1900
2026 Q1	–	Sell	-11,409	Closed	-$1.87M	–	2435
2025 Q4	$1.87M	Buy	+11,409	New	+$1.79M	0.02%	506
2025 Q3	–	Sell	-4,385	Closed	-$545K	–	2221
2025 Q2	$545K	Buy	+4,385	New	+$558K	﹤0.01%	1323
2024 Q3	–	Sell	-3,748	Closed	-$472K	–	1386
2024 Q2	$472K	Buy	+3,748	New	+$587K	﹤0.01%	627

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Brevan Howard Capital Management's RGEN Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Repligen (RGEN) in Q2 2026: 1,481 shares worth $202K. The stake represents ﹤0.01% of the portfolio and ranks #1900 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in RGEN as recently as Q4 2025.

Brevan Howard Capital Management first reported a position in RGEN in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.87M in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Brevan Howard Capital Management held 1,481 shares of Repligen worth $202K as of Q2 2026.
Repligen was a new Brevan Howard Capital Management position in Q2 2026.
Repligen made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1900 holding.
Brevan Howard Capital Management first reported a position in Repligen in Q2 2024 and has held it in 4 quarters since.
Brevan Howard Capital Management's Repligen position peaked at $1.87M in Q4 2025.
482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.